M1 Kliniken AG (ETR:M12)

Germany flag Germany · Delayed Price · Currency is EUR
16.42
-0.12 (-0.73%)
Apr 30, 2025, 5:36 PM CET
Market Cap 304.67M
Revenue (ttm) 333.27M
Net Income (ttm) 16.76M
Shares Out 18.56M
EPS (ttm) 0.91
PE Ratio 18.05
Forward PE 20.65
Dividend 0.50 (3.02%)
Ex-Dividend Date n/a
Volume 4,651
Average Volume 9,613
Open 16.58
Previous Close 16.54
Day's Range 16.42 - 16.90
52-Week Range 12.20 - 22.40
Beta 0.90
RSI 62.84
Earnings Date May 22, 2025

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for p... [Read more]

Sector Healthcare
Founded 2007
Employees 219
Stock Exchange Deutsche Börse Xetra
Ticker Symbol M12
Full Company Profile

Financial Performance

In 2023, M1 Kliniken AG's revenue was 316.32 million, an increase of 10.88% compared to the previous year's 285.29 million. Earnings were 10.27 million, an increase of 137.98%.

Financial Statements

News

EQS-Adhoc: M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment

EQS-Ad-hoc: M1 Kliniken AG / Key word(s): Investment/Miscellaneous M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment 01-Apr-2025 / 17:13 CET/CEST Disclosure of an in...

4 weeks ago - Wallstreet:Online

MPH Health Care: EBIT Hits €55.6M, Equity Soars to €300.3M, 94.85% Ratio

In a year marked by global challenges, MPH Health Care AG has shown remarkable financial resilience, with significant growth in EBIT and equity, while M1 Kliniken AG and CR Energy AG pursue ambitious ...

5 months ago - Wallstreet:Online

M1 Kliniken AG Boosts EBIT by 71% in 2024, Confirms Targets

M1 Kliniken AG has seen a remarkable surge in its financial performance, with a 71% rise in operating profit and a significant boost in its Beauty segment, setting ambitious global expansion goals. Je...

5 months ago - Wallstreet:Online

EQS-News: M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets

EQS-News: M1 Kliniken AG / Key word(s): Quarter Results/9 Month figures M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets 19.11....

5 months ago - Wallstreet:Online

MPH Health Care: H1 2024 EBIT Soars to €75.7M, Equity Hits €325.5M (€76.02/Share)

The preliminary IFRS results for the first half of 2024 reveal a robust financial performance, with significant EBIT growth and equity increases. M1 Kliniken AG expanded its market presence, while CR ...

8 months ago - Wallstreet:Online

M1 Kliniken AG Doubles EBIT, Sees Major Growth in H1 2024

M1 Kliniken AG has showcased impressive growth in early 2024, with sales up by 11.2% and EBIT nearly doubling. The Beauty segment saw a 30.6% sales surge, driving ambitious expansion plans and attract...

8 months ago - Wallstreet:Online

EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024

EQS-News: M1 Kliniken AG / Key word(s): Half Year Results/Quarter Results Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024 03.09.2024 / 08:45 C...

8 months ago - Wallstreet:Online